S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
The Charles Schwab Company Can Hit New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
Closing prices for crude oil, gold and other commodities
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
The Charles Schwab Company Can Hit New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
Closing prices for crude oil, gold and other commodities
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
The Charles Schwab Company Can Hit New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
Closing prices for crude oil, gold and other commodities
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
The Charles Schwab Company Can Hit New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
Closing prices for crude oil, gold and other commodities

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avantor, Inc. stock logo
AVTR
Avantor
$24.71
-1.0%
$24.86
$16.63
$26.16
$16.93B1.373.80 million shs2.40 million shs
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$300.41
0.0%
$333.00
$261.59
$489.36
$8.57B0.87174,899 shs167,913 shs
Bruker Co. stock logo
BRKR
Bruker
$85.75
-2.1%
$87.04
$53.79
$94.86
$12.06B1.17469,757 shs572,961 shs
Revvity, Inc. stock logo
PKI
Revvity
$127.73
$113.46
$170.00
$14.57B1.1851,117 shs1.63 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avantor, Inc. stock logo
AVTR
Avantor
-1.00%-3.74%-1.48%+13.09%+19.43%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-0.01%-7.93%-9.92%-4.70%-37.32%
Bruker Co. stock logo
BRKR
Bruker
-2.09%-4.97%-6.89%+20.91%+2.50%
Revvity, Inc. stock logo
PKI
Revvity
0.00%0.00%0.00%0.00%-15.95%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avantor, Inc. stock logo
AVTR
Avantor
4.2847 of 5 stars
2.42.00.03.23.42.53.1
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
4.6856 of 5 stars
3.44.00.04.21.93.31.9
Bruker Co. stock logo
BRKR
Bruker
4.7919 of 5 stars
2.24.01.73.81.94.23.1
Revvity, Inc. stock logo
PKI
Revvity
4.1375 of 5 stars
3.50.01.73.50.01.74.4

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avantor, Inc. stock logo
AVTR
Avantor
2.75
Moderate Buy$26.507.24% Upside
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
2.80
Moderate Buy$468.0055.79% Upside
Bruker Co. stock logo
BRKR
Bruker
2.43
Hold$84.86-1.04% Downside
Revvity, Inc. stock logo
PKI
Revvity
3.00
Buy$115.50∞ Upside

Current Analyst Ratings

Latest PKI, AVTR, BIO, and BRKR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2024
Avantor, Inc. stock logo
AVTR
Avantor
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$27.00 ➝ $30.00
4/10/2024
Bruker Co. stock logo
BRKR
Bruker
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSell ➝ Sell$66.00 ➝ $74.00
4/4/2024
Avantor, Inc. stock logo
AVTR
Avantor
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$26.00 ➝ $28.00
4/3/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$400.00 ➝ $365.00
3/1/2024
Bruker Co. stock logo
BRKR
Bruker
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$94.00 ➝ $102.00
2/16/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$395.00 ➝ $420.00
2/16/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$484.00 ➝ $480.00
2/15/2024
Avantor, Inc. stock logo
AVTR
Avantor
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$25.00 ➝ $29.00
2/15/2024
Avantor, Inc. stock logo
AVTR
Avantor
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$24.00 ➝ $30.00
2/15/2024
Avantor, Inc. stock logo
AVTR
Avantor
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$26.00 ➝ $29.00
2/15/2024
Avantor, Inc. stock logo
AVTR
Avantor
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$25.00 ➝ $26.00
(Data available from 4/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avantor, Inc. stock logo
AVTR
Avantor
$6.97B2.41$1.66 per share14.87$7.77 per share3.18
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.67B3.21$12.10 per share24.82$306.51 per share0.98
Bruker Co. stock logo
BRKR
Bruker
$2.96B3.98$3.50 per share24.51$10.08 per share8.51
Revvity, Inc. stock logo
PKI
Revvity
$3.31B0.00N/A9.88$58.49 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avantor, Inc. stock logo
AVTR
Avantor
$321.10M$0.4851.4819.931.574.61%14.11%5.50%4/26/2024 (Confirmed)
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-$637.32M-$21.49N/A25.81N/A-23.86%3.90%2.77%5/2/2024 (Estimated)
Bruker Co. stock logo
BRKR
Bruker
$427.20M$2.9229.3724.932.2214.41%29.94%9.68%5/2/2024 (Estimated)
Revvity, Inc. stock logo
PKI
Revvity
$569.18M$7.6815.010.000.5028.94%11.17%5.83%N/A

Latest PKI, AVTR, BIO, and BRKR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/26/2024N/A
Avantor, Inc. stock logo
AVTR
Avantor
$0.20N/A-$0.20N/AN/AN/A  
2/15/2024Q4 2023
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.93$3.10+$0.17-$5.94$685.00 million$681.18 million      
2/14/202412/31/2023
Avantor, Inc. stock logo
AVTR
Avantor
$0.22$0.25+$0.03$0.35$1.70 billion$1.72 billion      
2/13/202412/31/2023
Bruker Co. stock logo
BRKR
Bruker
$0.65$0.70+$0.05-$0.01$809.35 million$844.50 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avantor, Inc. stock logo
AVTR
Avantor
N/AN/AN/AN/AN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
N/AN/AN/AN/AN/A
Bruker Co. stock logo
BRKR
Bruker
$0.200.23%+7.72%6.85%N/A
Revvity, Inc. stock logo
PKI
Revvity
$0.28N/AN/A3.65%N/A

Latest PKI, AVTR, BIO, and BRKR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/15/2024
Bruker Co. stock logo
BRKR
Bruker
Quarterly$0.050.25%2/29/20243/1/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avantor, Inc. stock logo
AVTR
Avantor
1.00
1.61
1.05
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.14
5.83
4.34
Bruker Co. stock logo
BRKR
Bruker
0.83
1.80
0.99
Revvity, Inc. stock logo
PKI
Revvity
0.48
2.43
2.15

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Avantor, Inc. stock logo
AVTR
Avantor
95.08%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
65.24%
Bruker Co. stock logo
BRKR
Bruker
79.52%
Revvity, Inc. stock logo
PKI
Revvity
85.22%

Insider Ownership

CompanyInsider Ownership
Avantor, Inc. stock logo
AVTR
Avantor
1.30%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
17.50%
Bruker Co. stock logo
BRKR
Bruker
28.20%
Revvity, Inc. stock logo
PKI
Revvity
0.52%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Avantor, Inc. stock logo
AVTR
Avantor
14,500678.28 million669.46 millionOptionable
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
8,03028.52 million23.53 millionOptionable
Bruker Co. stock logo
BRKR
Bruker
9,707137.67 million98.85 millionOptionable
Revvity, Inc. stock logo
PKI
Revvity
16,700126.41 million125.76 millionOptionable

PKI, AVTR, BIO, and BRKR Headlines

SourceHeadline
Revvity Inc PKIRevvity Inc PKI
morningstar.com - February 13 at 11:31 PM
Revvity revenue drops 17% in first year after PerkinElmer spinout, thanks to COVID testing declinesRevvity revenue drops 17% in first year after PerkinElmer spinout, thanks to COVID testing declines
fiercebiotech.com - February 1 at 1:35 PM
PerkinElmer buys Covaris to boost next-gen life sciences offeringsPerkinElmer buys Covaris to boost next-gen life sciences offerings
mmm-online.com - December 4 at 6:14 PM
PerkinElmer picks up Covaris’ sample prep portfolio in New Mountain-led dealPerkinElmer picks up Covaris’ sample prep portfolio in New Mountain-led deal
fiercebiotech.com - December 4 at 1:13 PM
Revvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCIDRevvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCID
businesswire.com - December 1 at 12:46 PM
Revvity and Sciex Collaborate To Provide Innovative Neonatal Mass Spectrometry SolutionRevvity and Sciex Collaborate To Provide Innovative Neonatal Mass Spectrometry Solution
technologynetworks.com - November 1 at 1:55 AM
Revvity Stock (NYSE:RVTY), Analyst Ratings, Price Targets, PredictionsRevvity Stock (NYSE:RVTY), Analyst Ratings, Price Targets, Predictions
benzinga.com - November 1 at 1:55 AM
Revvity, Inc. and Element Biosciences, Inc. Pioneer Next-Generation Sequencing Kits Market with Innovative Genomic Analysis SolutionsRevvity, Inc. and Element Biosciences, Inc. Pioneer Next-Generation Sequencing Kits Market with Innovative Genomic Analysis Solutions
finance.yahoo.com - October 29 at 11:18 AM
Revvity, IncRevvity, Inc
moneycontrol.com - August 3 at 2:11 AM
Revvity (RVTY) Beats on Q2 Earnings, Lowers 23 EPS ViewRevvity (RVTY) Beats on Q2 Earnings, Lowers '23 EPS View
finance.yahoo.com - August 2 at 11:03 AM
Revvity (NYSE: PKI)Revvity (NYSE: PKI)
fool.com - August 1 at 8:00 PM
Revvity (RVTY) to Report Q2 Earnings: Whats in the Cards?Revvity (RVTY) to Report Q2 Earnings: What's in the Cards?
finance.yahoo.com - July 31 at 10:32 AM
PerkinElmer Completes Transformation to Become RevvityPerkinElmer Completes Transformation to Become Revvity
finance.yahoo.com - May 19 at 2:37 PM
Revvity Announces New License Agreement for Next-Generation Base Editing TechnologyRevvity Announces New License Agreement for Next-Generation Base Editing Technology
finance.yahoo.com - May 18 at 10:18 AM
J.P. Morgan Keeps Their Hold Rating on PerkinElmer (PKI)J.P. Morgan Keeps Their Hold Rating on PerkinElmer (PKI)
markets.businessinsider.com - May 16 at 12:37 PM
Citigroup Maintains Revvity (PKI) Buy RecommendationCitigroup Maintains Revvity (PKI) Buy Recommendation
msn.com - May 15 at 9:36 PM
Analyst Ratings for RevvityAnalyst Ratings for Revvity
markets.businessinsider.com - May 15 at 4:36 PM
PerkinElmer (PKI) Receives a Buy from CitigroupPerkinElmer (PKI) Receives a Buy from Citigroup
markets.businessinsider.com - May 15 at 9:40 AM
Barclays Maintains Perkinelmer (PKI) Equal-Weight RecommendationBarclays Maintains Perkinelmer (PKI) Equal-Weight Recommendation
msn.com - May 13 at 8:08 AM
PerkinElmer: Q1 Earnings Snapshot - Seattle PIPerkinElmer: Q1 Earnings Snapshot - Seattle PI
news.google.com - May 12 at 9:15 PM
PerkinElmer Q1 23 Earnings Conference Call At 8:00 AM ET - NasdaqPerkinElmer Q1 23 Earnings Conference Call At 8:00 AM ET - Nasdaq
news.google.com - May 12 at 9:15 PM
Skandinaviska Enskilda Banken AB publ Has $2.92 Million Position ... - MarketBeatSkandinaviska Enskilda Banken AB publ Has $2.92 Million Position ... - MarketBeat
news.google.com - May 12 at 9:15 PM
PerkinElmer Non-GAAP EPS of $1.01 misses by $0.01, revenue of ... - Seeking AlphaPerkinElmer Non-GAAP EPS of $1.01 misses by $0.01, revenue of ... - Seeking Alpha
news.google.com - May 12 at 9:15 PM
PerkinElmer Enters Oversold Territory (PKI) - NasdaqPerkinElmer Enters Oversold Territory (PKI) - Nasdaq
news.google.com - May 12 at 9:15 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Avantor logo

Avantor

NYSE:AVTR
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Bio-Rad Laboratories logo

Bio-Rad Laboratories

NYSE:BIO
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Bruker logo

Bruker

NASDAQ:BRKR
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Revvity logo

Revvity

NYSE:PKI
Revvity, Inc provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics.? The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.